Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: A case-control study

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 4, 2009, Pages 406-413

  Tseng, G Y ^b,c   Fang, C T ^d   Lin, H J ^a,b   Yang, H B ^e   Tseng, G C ^b   Wang, P C ^b   Liao, P C ^b   Cheng, Y T ^d   Huang, C H ^d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; CASE CONTROL STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPIC THERAPY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; TREATMENT FAILURE; UREMIA;

AGED; ANTI-ULCER AGENTS; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; FEMALE; HEMOSTASIS, ENDOSCOPIC; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS; REGRESSION ANALYSIS; TREATMENT OUTCOME; UREMIA; VASOCONSTRICTOR AGENTS;

EID: 67651176289     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04049.x     Document Type: Article

References (34)

1. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med 2008 359 : 928 37.
2. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology 1992 102 : 139 48.
3. Leontiadias G, Sharma VK, Howden CW, et al. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 2007 82 : 286 96.
4. Leontiadias G, Sharma VK, Howden CW, et al. Proton pump inhibitor therapy for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006 1 : CD002094.
5. Lin HJ, Lo WC, Lee FY, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Int Med 1998 158 : 54 8.
6. Calvet X, Vergara M, Brullet E, et al. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high risk bleeding ulcers. Gastroenterology 2004 126 : 441 50.
7. Lin HJ, Lo WC, Cheng YC, et al. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol 2006 101 : 500 5.
8. Cheng HC, Chuang SA, Kao YH, et al. Increased risk of rebleeding of peptic ulcer bleeding in patients with co-morbid illness receiving omeprazole infusion. Hepato-gastroenterol 2003 50 : 2270 3.
9. Cheng HC, Kao AW, Chuang CH, et al. The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Digest Dis Sci 2005 50 : 1194 201.
10. Tseng GY, Lin HJ, Fang CT, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther 2007 26 : 925 33.
11. Keane WF, Swan SK, Grimes I, Humphries TJ. Rabeprazole: Pharmacokinetics and tolerability in patients with stable, end-stage renal failure. J Clin Pharmacol 1999 39 : 927 33.
12. Ventkateswaren PS, Jeffers A, Hocken AG. Gastric acid secretion in chronic renal failure. Brit Med J 1972 4 : 22 3.
13. Muto S, Asano Y, Hosoda S, Miyata M. Hypochlorhydria and hypergastrinemia and their association with gastro-intestinal bleeding in undialyzed and hemodialyzed patients. Nephron 1988 50 : 10 3.
14. Gold CH, Morley JE, Viljoen M, et al. Gastric secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis. Nephron 1980 25 : 92 5.
15. Watanabe H, Hiraishi H, Ishida M, Kazama JJ, Terano A. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection. J Intern Med 2003 254 : 439 46.
16. Lin HJ, Tseng GY, Hsieh YH, et al. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy? Am J Gastroenterol 1999 94 : 3184 8.
17. Zhang L, Zou L, Wang F, et al. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol 2006 17 : 2617 21.
18. Hou FF, Ma ZG, Mei CL, et al. Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients. Zhong Hua Yi Xue Za Zhi 2005 85 : 753 9.
19. Yasuhara H, Hattori T, Shigeta O. Significance of phlebo-sclerosis in non-healing ischemic foot ulcers of end-stage renal disease. Eur J Vasc Endovas Surg 2008 36 : 346 52.
20. Vaziri ND, Smith DB, Miller R, et al. Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol 1985 80 : 608 11.
21. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006 19 : 317 22.
22. Sabovic M, Salobir B, Preloznik Zupan I, et al. The influence of the hemodialysis procedure on platelet, coagulation and fibrinolysis. Pathophysiol Haemost Throm 2005 34 : 274 8.
23. Powe NR, Jaar B, Furth SL. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999 55 : 1081 90.
24. Nissenson AR, Dylan ML, Griffiths RI, et al. Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin. Clin J Am Soc Nephrol 2006 1 : 505 10.
25. Mann JFE. What are the short-term and long-term consequences of anemia in CRF patients. Nephrol Dial Transpl 1999 14 (S2 29 36.
26. Madore F, Lowrie E, Brugnara C, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997 8 : 1921 9.
27. Ma J, Ebben J, Xia H, Collins A. Hematocrit level and associated mortality in hemodialysis patients. J Am Scoc Nephrol 1999 10 : 610 9.
28. Lin HJ, Hsieh YH, Tseng GY, et al. A prospective, randomized trial of large- versus small- volume endoscopic injection of epinephrine for peptic ulcer bleeding. Gastrointest Endosc 2002 55 : 615 9.
29. Goldstein JA, Ishizaki T, Chiba K, et al. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black population. Pharmacogenetics 1997 7 : 59 64.
30. Feldman M, Richardson CT, Lam SK, Samloff IM. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients. Gastroenterology 1988 95 : 630 5.
31. Rackall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal hemorrhage. Gut 1996 38 : 316 21.
32. Masaoka T, Suzuki H, Hori S, et al. Blatchford scoring system is a useful scoring system for detecting patients with upper gastrointestinal bleeding who do not need endoscopic intervention. J Gastroenterol Hepatol 2006 22 : 1404 8.
33. Marmo R, Rontondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high risk bleeding ulcer: a meta-analysis of controlled trials. Am J Gastroenterology 2007 102 : 279 89.
34. Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M. Endoscopic hemostasis in peptic ulcer bleeding for patients with high risk lesions: a series of meta-analysis. Gastrointest Endosc 2009 69 : 786 99.